Showing results (71-80 of 117) with videos related to

Sort By:
Pageof 12
Arthritis Research & Therapy|July 9, 2025
Receptor activator of nuclear factor-kappa B ligand-derived microglia healing peptide 1-AcN inhibits osteoarthritis progression in miceYuji Fukuda, Munehisa Shimamura, Yuki Etani, et al.
International Journal of Molecular Sciences|June 13, 2025
Effects of Sleeve Gastrectomy and Treadmill Exercise on Skeletal Muscle and Ectopic Fat in High-Fat Diet-Induced Obese RatsTakaaki Noguchi, Yuichi Yoshida, Koro Gotoh, et al.
Scientific Reports|November 22, 2019
A Miocene impact ejecta layer in the pelagic Pacific OceanTatsuo Nozaki, Junichiro Ohta, Takaaki Noguchi, et al.
Modern Rheumatology|January 22, 2024
Early full weight-bearing and gait exercise after cemented total ankle arthroplasty with a modified anterolateral approachManabu Sakata, Makoto Hirao, Takaaki Noguchi, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|September 16, 2023
Effects of esaxerenone on blood pressure, urinary albumin excretion, serum levels of NT-proBNP, and quality of life in patients with primary aldosteronismYuichi Yoshida, Mio Fujiwara, Mizuki Kinoshita, et al.
Frontiers in Endocrinology|September 15, 2025
Short-term longitudinal clinical, biochemical, and quality of life outcomes of medical or surgical therapy in unilateral primary aldosteronismYuichi Yoshida, Kentaro Sada, Yoshiro Matsuo, et al.
JCI Insight|December 6, 2024
The pivotal role of the Hes1/Piezo1 pathway in the pathophysiology of glucocorticoid-induced osteoporosisNagahiro Ochiai, Yuki Etani, Takaaki Noguchi, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|November 15, 2024
Antihypertensive effects and changes in extracellular water content by mineralocorticoid receptor antagonists in patients with primary aldosteronismNaoki Matsuda, Yuichi Yoshida, Naruto Inobe, et al.
Pageof 12